Order of the President of the General Court of 19 August 2019 — BASF v Commission

(Case T-472/19 R R)

(Interim measures — Medicinal product — Marketing authorisation —Omega-3 acid ethyl esters — No urgency)

Language of the case: English

Parties

Applicant: BASF AS (Oslo, Norway) (represented by: E. Wright, A. Rusanov and H. Boland, lawyers)

Defendant: European Commission (represented by: L. Haasbeek and A. Sipos, Agents)

Re:

Application pursuant to Articles 278 TFEU and 279 TFEU for the grant of interim measures to suspend the operation of the Commission Implementing Decision of 6 June 2019 concerning, in the framework of Article 31 of Directive 2001/83/EC, the marketing authorisations of medicinal products for human use containing ‘Omega-3 acid ethyl esters’ for oral use in secondary prevention after myocardial infarction (C(2019) 4336 final).

Operative part of the order

1.    The application for interim measures is dismissed.

2.    The costs are reserved.

____________